N@N

Anupam Rama Maintained (BBIO) at Buy with Decreased Target to $43 on, Aug 7th, 2024

^{Published on 2024-10-28 13:18:44 - WOPRAI, Anupam Rama}
 

Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $46 to $43 on, Aug 7th, 2024.

Anupam has made no other calls on BBIO in the last 4 months.

There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 0 agree with Anupam's Rating of Hold.

These are the ratings of the 4 analyists that currently disagree with Anupam

---

• Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Monday, August 5th, 2024
• Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, July 1st, 2024
• Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
• Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024

Contributing Sources

---